Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01652976
Title Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Florida

pancreatic adenocarcinoma


Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab


Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UF Health Cancer Center Gainesville Florida 32610 United States Details
*Shaded cells indicate that there was no data available from for the field